1,228
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Challenges Facing MicroRNA Therapeutics for Cystic Fibrosis Lung Disease

& ORCID Icon
Pages 179-181 | Received 19 Dec 2019, Accepted 10 Jan 2020, Published online: 03 Feb 2020
 

Financial & competing interests disclosure

Funding for research in this group is gratefully acknowledged from Cystic Fibrosis Foundation Therapeutics (GREENE15XXO) and the NIH (R01HL144539). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

Funding for research in this group is gratefully acknowledged from Cystic Fibrosis Foundation Therapeutics (GREENE15XXO) and the NIH (R01HL144539). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.